# GentiBio

presented preclinical data for GNTI-122, its autologous antigen-specific engineered Treg lead, an approach designed to restore tolerance with tissue-restricted specificity.

Source: https://en.bioecon.ru/companies/gentibio/
Updated: 2026-07-20

- Country: United States

## Technologies

- [Stem cell therapy for autoimmune disease](https://en.bioecon.ru/technology/stem-cell-therapy-autoimmune/)